Creation, Implementation, and Analysis of a Seizure Action Plan
NCT02995759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 288
Last updated 2019-08-06
Summary
Data strongly suggests that aggressive and early treatment of status epilepticus (SE) is crucial for seizure abortion and prevention of long-term neurologic sequelae. We propose the creation of a seizure action plan, an intervention aimed to guide daily medication use, outline pre-hospital seizure first aid and rescue medication use, and direct emergency personnel in patients' individualized SE medication algorithm, with implementation through the electronic medical record. We hypothesize that the seizure action plan will promote daily medication adherence, increase use of home rescue mediation, and improve timeliness of AED (antiepileptic drug) delivery, length of hospital stay, and ICU admission rate in episodes of status epilepticus.
Conditions
- Epilepsy
- Status Epilepticus
Interventions
- OTHER
-
Seizure Action Plan
The action plan will be electronically formatted in the EMR. After electronic creation, the primary neurologist and patient/caregiver will create a patient-specific plan.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Tobias Loddenkemper, MD · Boston Children's Hospital
Eligibility
- Min Age
- 1 Month
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2019-04-30
- Completion
- 2019-04-30
Countries
- United States
Study Locations
More Related Trials
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3
-
Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)
NCT02925663 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193 ·Status: COMPLETED ·Phase: PHASE3
-
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
NCT02239276 ·Status: NO_LONGER_AVAILABLE
-
Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
NCT03350035 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Topiramate in Childhood Absence Epilepsy
NCT00210574 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Clinical Study of Children With Status Epilepticus in China
NCT03378687 ·Status: UNKNOWN
-
Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children
NCT02821260 ·Status: RECRUITING
-
Seizures Post Intracerebral Hemorrhage
NCT01115959 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Therapy In Status Epilepticus
NCT04391569 ·Status: COMPLETED ·Phase: PHASE3
-
Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
NCT03753035 ·Status: UNKNOWN
-
Ketamine for the Treatment of Refractory Status Epilepticus
NCT07177235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
NCT03336242 ·Status: TERMINATED ·Phase: PHASE2
-
Lorazepam for the Treatment of Status Epilepticus in Children
NCT00114569 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
NCT05374824 ·Status: RECRUITING
-
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT04290975 ·Status: COMPLETED ·Phase: NA
-
Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan
NCT03336645 ·Status: COMPLETED ·Phase: PHASE3
-
Sleep Intervention for Pediatric Epilepsy
NCT02514291 ·Status: COMPLETED ·Phase: NA
-
Safety of Autologous MSC Infusion to Treat Epilepsy
NCT02497443 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial for Epilepsy Patients Non-responsive to AEDs Using Medical App
NCT03747705 ·Status: UNKNOWN
-
Surgery as a Treatment for Medically Intractable Epilepsy
NCT01273129 ·Status: RECRUITING
-
Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures
NCT01268904 ·Status: UNKNOWN
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED